» Authors » Katsuhiko Okubo

Katsuhiko Okubo

Explore the profile of Katsuhiko Okubo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 135
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Inoue K, Ninomiya J, Saito T, Okubo K, Nakakuma T, Yamada H, et al.
Invest New Drugs . 2019 Apr; 37(3):592-593. PMID: 31025237
The authors would like to note the replacement of Fig. 2b, for which Fig. 2a was placed erringly, with appropriate Fig. 2b.
2.
Inoue K, Ninomiya J, Saito T, Okubo K, Nakakuma T, Yamada H, et al.
Invest New Drugs . 2019 Mar; 37(3):538-547. PMID: 30848403
Purpose To examine the efficacy and safety of triple therapy with eribulin, trastuzumab, and pertuzumab in patients with HER2-positive metastatic breast cancer (MBC) who never received any prior therapy in...
3.
Inoue K, Saito T, Okubo K, Kimizuka K, Yamada H, Sakurai T, et al.
Breast Cancer Res Treat . 2016 Apr; 157(2):295-305. PMID: 27125669
No clinical evidence on the efficacy and safety of eribulin monotherapy has been obtained by a prospective clinical study in patients with metastatic breast cancer (MBC) who had well-defined taxane...
4.
Takeuchi H, Saeki T, Shigekawa T, Sano H, Nakamiya N, Matsuura K, et al.
Surg Today . 2010 Aug; 40(8):706-10. PMID: 20676852
Purpose: A novel approach was introduced for breast surgery using the BiClamp, a new bipolar thermal energy device, to avoid complications and to shorten the time required for the dissection...
5.
Aoyagi H, Kaneko J, Makinose T, Someno Y, Katsuta E, Saguchi M, et al.
Gan To Kagaku Ryoho . 2009 Dec; 36(12):2474-6. PMID: 20037460
In November 2005, a 34-year-old female presented to our department with a bleeding tumor on her right breast. She noticed the tumor approximately two years ago but she left it...
6.
Fujiuchi N, Saeki T, Takeuchi H, Sano H, Takahashi T, Matsuura K, et al.
Breast Cancer . 2009 Jun; 18(2):141-4. PMID: 19554397
Recent advanced imaging modalities such as positron emission tomography (PET) detect malignancies using 2-[18F]-fluoro-2-deoxy-D: -glucose (18-FDG) with high accuracy, and they contribute to decisions regarding diagnosis, staging, recurrence, and treatment...
7.
Shigekawa T, Takeuchi H, Misumi M, Matsuura K, Sano H, Fujiuchi N, et al.
Breast Cancer . 2008 May; 16(1):88-92. PMID: 18478315
We report a case of metastatic breast cancer with leptomeninges and multiple bone metastases that showed an excellent response to the combination of trastuzumab and capecitabine; therapeutic effect was evaluated...
8.
Takei H, Suemasu K, Inoue K, Saito T, Okubo K, Koh J, et al.
Breast Cancer Res Treat . 2007 Nov; 107(1):87-94. PMID: 18043897
This multicenter phase II trial evaluated the efficacy and tolerability of 4 months of neoadjuvant exemestane in 44 postmenopausal patients with estrogen receptor (ER)-positive and/or progesterone receptor-positive, stage II to...
9.
Murakami S, Sakata H, Okubo K, Tsuji Y, Kayano H
Surg Today . 2007 Mar; 37(3):226-9. PMID: 17342362
A thyroid tumor with extensive extracellular mucin deposition is extremely rare. We herein describe a case of a thyroid adenoma with prominent myxoid stroma. A 63-year-old man presented with a...
10.
Takeuchi H, Okubo K, Fujiuchi N, Saeki T
Gan To Kagaku Ryoho . 2006 Jun; 33(6):736-41. PMID: 16770090
Breast cancer is one of the most common malignancies among Japanese women. Approximately 40,000 new patients are diagnosed annually. In the USA, however,the mortality from breast cancer has recently been...